Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis

Clinical trial NCT05986162 · UNKNOWN

Trial details

NCT number: NCT05986162
Sponsor: Biotech Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Dermatomyositis, Adult Type

Start date: 2023-12-30
Primary completion: 2025-05-03
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.